Cylexin: Began Phase I trial

Cytel Corp. (CYTL), San Diego Product: Cylexin (CY1503) small molecule carbohydrate blocker of P and E selectins Indication: Reperfusion injury after heart attack and lung surgery Status: Began Phase...